Keywords: trillium, secures, 12m, financing, therapeutics, privately-held, canadian

Trillium secures C$12M financing

Article | 22 September 2008

Trillium Therapeutics, a privately-held Canadian biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing